Cytek Biosciences, Inc.
CTKB
$4.81
$0.153.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -80.58M | -74.00M | -66.54M | -12.82M | -6.40M |
| Total Depreciation and Amortization | 11.90M | 11.90M | 11.98M | 11.67M | 11.42M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.49M | 53.63M | 54.67M | 6.05M | 10.18M |
| Change in Net Operating Assets | 6.15M | 1.18M | -4.79M | -6.82M | 3.00K |
| Cash from Operations | -6.04M | -7.30M | -4.69M | -1.92M | 15.20M |
| Capital Expenditure | -6.04M | -5.40M | -4.08M | -3.98M | -4.33M |
| Sale of Property, Plant, and Equipment | 205.00K | 225.00K | 252.00K | 248.00K | 268.00K |
| Cash Acquisitions | -- | -- | -- | -471.00K | -471.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.86M | -21.24M | 13.95M | -47.27M | -81.67M |
| Cash from Investing | -2.98M | -26.41M | 10.12M | -51.47M | -86.20M |
| Total Debt Issued | 8.62M | 9.96M | 5.58M | 6.95M | 4.87M |
| Total Debt Repaid | -5.57M | -4.10M | -4.75M | -1.94M | -1.94M |
| Issuance of Common Stock | 1.63M | 1.46M | 1.47M | 1.78M | 1.79M |
| Repurchase of Common Stock | -799.00K | -5.23M | -15.74M | -22.63M | -34.59M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.00K | 1.00K | 1.00K | -- | -- |
| Cash from Financing | 3.88M | 2.09M | -13.43M | -15.85M | -29.87M |
| Foreign Exchange rate Adjustments | 3.51M | 1.98M | 109.00K | 215.00K | -1.57M |
| Miscellaneous Cash Flow Adjustments | 1.00K | 0.00 | 0.00 | 0.00 | -1.00K |
| Net Change in Cash | -1.62M | -29.63M | -7.89M | -69.02M | -102.45M |